Jason Lettmann

Insider Reports History

Entity
Individual
Location
C/O Ra Pharmaceuticals, Inc., 87 Cambridgepark Drive, Cambridge, MA
Signature
/s/ Shelly Pinto, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Lettmann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALX ONCOLOGY HOLDINGS INC CHIEF EXECUTIVE OFFICER, Director Common Stock 169K $437K $2.58 Aug 14, 2024 Direct
ALX ONCOLOGY HOLDINGS INC CHIEF EXECUTIVE OFFICER, Director Employee Stock Option (right to buy) 200K Dec 2, 2024 Direct
ALX ONCOLOGY HOLDINGS INC CHIEF EXECUTIVE OFFICER, Director Employee Stock Option 190K Feb 14, 2024 Direct

Insider Reports Filed by Jason Lettmann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALXO ALX ONCOLOGY HOLDINGS INC Dec 2, 2024 1 $0 4 Dec 4, 2024 CHIEF EXECUTIVE OFFICER, Director
ALXO ALX ONCOLOGY HOLDINGS INC Aug 14, 2024 1 -$5.65K 4 Aug 16, 2024 CHIEF EXECUTIVE OFFICER, Director
ALXO ALX ONCOLOGY HOLDINGS INC Mar 14, 2024 1 $49.8K 4 Mar 18, 2024 CHIEF EXECUTIVE OFFICER, Director
ALXO ALX ONCOLOGY HOLDINGS INC Feb 14, 2024 2 $0 4 Feb 16, 2024 CHIEF EXECUTIVE OFFICER, Director
ALXO ALX ONCOLOGY HOLDINGS INC Sep 8, 2023 1 $0 4 Sep 12, 2023 Chief Executive Officer, Director
ALXO ALX ONCOLOGY HOLDINGS INC Jun 20, 2023 1 $0 4 Jun 22, 2023 Director, 10%+ Owner
ALXO ALX ONCOLOGY HOLDINGS INC Jun 15, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
ALXO ALX ONCOLOGY HOLDINGS INC Dec 13, 2021 12 -$8.9M 4 Dec 15, 2021 Director, 10%+ Owner
ALXO ALX ONCOLOGY HOLDINGS INC Dec 8, 2021 16 -$4.7M 4 Dec 10, 2021 Director, 10%+ Owner
ALXO ALX ONCOLOGY HOLDINGS INC Jun 11, 2021 1 $0 4 Jun 15, 2021 Director